Literature DB >> 19214300

Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention.

Jaroslav Hubacek1, Rashpal S Basran, Fiona M Shrive, Lana Shewchuk, David M Goodhart, Todd J Anderson.   

Abstract

BACKGROUND: C-reactive protein (CRP), a marker of inflammation, plays a role in the pathophysiology of atherosclerotic events. The relationship between CRP levels and myocardial necrosis assessed by troponin T (TnT) in patients undergoing percutaneous coronary intervention (PCI) has not been established. In addition, the long-term significance of TnT rise following PCI is not clear.
OBJECTIVES: To examine the relationship between CRP and the rise in TnT levels, and evaluate the long-term prognostic implications of TnT rise following PCI.
METHODS: A total of 1208 patients underwent successful nonemergent PCI. Baseline demographic characteristics, CRP and TnT levels were prospectively collected before and 12 h to 18 h following PCI. Long-term follow-up data over two years were available.
RESULTS: Among the patients studied (mean age 62 years), 64% presented with acute coronary syndrome. A PCI procedure was associated with a significant increase in TnT levels (higher than 0.1 microg/L) in 238 patients (20%). Multivariate logistic regression identified presentation with acute coronary syndrome or myocardial infarction, no statin use at the time of the procedure, increased CRP and increasing length of stent as independent predictors of TnT rise following PCI. Periprocedural TnT rise was not associated with adverse events in follow-up examinations (OR 1.09, 95% CI 0.73 to 1.65).
CONCLUSIONS: Myocardial necrosis commonly occurred in otherwise successful PCI and was particularly prevalent in the proinflammatory milieu of a recent myocardial infarction. This response was blunted with statin therapy. However, there was no long-term adverse sequelae of these troponin rises following otherwise uncomplicated PCI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214300      PMCID: PMC2691917          DOI: 10.1016/s0828-282x(09)70483-0

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  27 in total

1.  Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  F Haverkate; S G Thompson; S D Pyke; J R Gallimore; M B Pepys
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

Review 2.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

3.  Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.

Authors:  Joseph B Selvanayagam; Italo Porto; Keith Channon; Steffen E Petersen; Jane M Francis; Stefan Neubauer; Adrian P Banning
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

4.  Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty.

Authors:  A Buffon; G Liuzzo; L M Biasucci; P Pasqualetti; V Ramazzotti; A G Rebuzzi; F Crea; A Maseri
Journal:  J Am Coll Cardiol       Date:  1999-11-01       Impact factor: 24.094

5.  Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

Authors:  P M Ridker; N Rifai; M A Pfeffer; F M Sacks; L A Moye; S Goldman; G C Flaker; E Braunwald
Journal:  Circulation       Date:  1998-09-01       Impact factor: 29.690

6.  Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I.

Authors:  C W Hamm; B U Goldmann; C Heeschen; G Kreymann; J Berger; T Meinertz
Journal:  N Engl J Med       Date:  1997-12-04       Impact factor: 91.245

7.  C-reactive protein levels and outcomes after statin therapy.

Authors:  Paul M Ridker; Christopher P Cannon; David Morrow; Nader Rifai; Lynda M Rose; Carolyn H McCabe; Marc A Pfeffer; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

8.  Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.

Authors:  Abhiram Prasad; Mandeep Singh; Amir Lerman; Ryan J Lennon; David R Holmes; Charanjit S Rihal
Journal:  J Am Coll Cardiol       Date:  2006-10-17       Impact factor: 24.094

9.  C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.

Authors:  D A Morrow; N Rifai; E M Antman; D L Weiner; C H McCabe; C P Cannon; E Braunwald
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

10.  Elevations in troponin I after percutaneous coronary interventions are associated with abnormal tissue-level perfusion in high-risk patients with non-ST-segment-elevation acute coronary syndromes.

Authors:  Leonardo Bolognese; Kenneth Ducci; Paolo Angioli; Giovanni Falsini; Francesco Liistro; Silvia Baldassarre; Antonio Burali
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

View more
  4 in total

1.  Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study.

Authors:  Liding Zhao; Ya Li; Tian Xu; Yi Luan; Qingbo Lv; Yao Wang; Xue Lv; Guosheng Fu; Wenbin Zhang
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

2.  Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Authors:  Issam D Moussa; Lloyd W Klein; Binita Shah; Roxana Mehran; Michael J Mack; Emmanouil S Brilakis; John P Reilly; Gilbert Zoghbi; Elizabeth Holper; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2013-10-22       Impact factor: 24.094

3.  Predictive value of baseline C-reactive protein for periprocedural myocardial infraction of higher risk stratifications: A retrospective cohort clinical study.

Authors:  Mingyang Yao; Linlin Zhao; Lili Wu; Wenbin Zhang; Yi Luan; Jiale Song; Guosheng Fu; Junhui Zhu
Journal:  Anatol J Cardiol       Date:  2018-09-17       Impact factor: 1.596

4.  Myocardial damage associated with elective percutaneous coronary intervention in Chinese patients: a retrospective study.

Authors:  Shengjia Sun; Yang Ou; Haiming Shi; Jianfeng Luo; Xinping Luo; Yunzhi Shen; Yufei Chen; Xiaojin Liu; Zhidong Zhu; Wei Shen
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.